A new entrant to the list of top 10 pharmaceuticals is Bristol-Myers Squibb
Bristol-Myers Squibb (BMS)
US $ 22.6 billion
A new entrant to the list of top 10 pharmaceuticals is Bristol-Myers Squibb, a leading American pharmaceutical company headquartered in New York City. BMS specializes in four treatment areas: oncology, cardiovascular, immunoscience and fibrosis. The strong growth of the company in 2018 may be responsible for the continued success of leading drugs, Opdivo (cancer) and aliquots (blood thinners) in a part. BMS's success could be further enhanced by a company planned by Celgene's innovative oncology biotech - early 20 This.
US $ 22.6 billion
A new entrant to the list of top 10 pharmaceuticals is Bristol-Myers Squibb, a leading American pharmaceutical company headquartered in New York City. BMS specializes in four treatment areas: oncology, cardiovascular, immunoscience and fibrosis. The strong growth of the company in 2018 may be responsible for the continued success of leading drugs, Opdivo (cancer) and aliquots (blood thinners) in a part. BMS's success could be further enhanced by a company planned by Celgene's innovative oncology biotech - early 20 This.
No comments